Energenesis Biomedical CO.,LTD. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was TWD 1.51 million compared to TWD 2 million a year ago. Net loss was TWD 45.16 million compared to TWD 119.61 million a year ago. Basic loss per share from continuing operations was TWD 0.59 compared to TWD 1.8 a year ago.
For the nine months, sales was TWD 4.92 million compared to TWD 4.86 million a year ago. Net loss was TWD 198.05 million compared to TWD 219.96 million a year ago. Basic loss per share from continuing operations was TWD 2.8 compared to TWD 3.3 a year ago.